Junbiao Chang

机构：China Pharmaceutical University, Henan Normal University · ORCID：0000-0001-6236-1256

发表论文 501 篇 · 总被引 14428 次 · h-index 53

代表论文

• Thinking on the Use of Artificial Intelligence in Drug Discovery (2025 · Journal of Medicinal Chemistry · 被引 12)
• Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study (2025 · Signal Transduction and Targeted Therapy · 被引 10)
• Discovery of a 2′-α-Fluoro-2′-β- C -(fluoromethyl) Purine Nucleotide Prodrug as a Potential Oral Anti-SARS-CoV-2 Agent (2025 · Journal of Medicinal Chemistry · 被引 10)
• Design, Synthesis, and Biological Evaluation of 1,3,4-Thiadiazole Derivatives as Novel Potent Peptide Deformylase Inhibitors for Combating Drug-Resistant Gram-Positive and -Negative Bacteria (2025 · Journal of Medicinal Chemistry · 被引 10)
• Structure-Based Design of New LSD1/EGFR L858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers (2025 · Journal of Medicinal Chemistry · 被引 8)
• Cyclization-enhanced photoactivatable reversible room-temperature phosphorescence for efficient real-time light printing (2025 · Chemical Science · 被引 5)